Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hematologic Malignancies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hematologic Malignanciesmarket, defines the market attractiveness level of Hematologic Malignancies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hematologic Malignancies industry, describes the types of Hematologic Malignancies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hematologic Malignancies market and the development prospects and opportunities of Hematologic Malignancies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hematologic Malignancies market in Chapter 13.
By Player:
Nоvаrtіѕ АG
Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd
Ѕаnоfі-Аvеntіѕ
Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ
Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу
F Ноffmаnn-LА Rосhе ltd
Сеlgеnе Соrроrаtіоn
Іnс
Рfіzеr Іnс
АbbVіе Іnс
GlахоЅmіthКlіnе РLС
By Type:
Leukemia
Lymphoma
Multiple Myeloma
Others
By End-User:
Chemotherapy
Radiotherapy
Immunotherapy
Stem Cell Transplantation
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hematologic Malignancies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hematologic Malignancies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hematologic Malignancies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hematologic Malignancies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hematologic Malignancies Market Analysis and Outlook to 2022
-
7.1 Global Hematologic Malignancies Consumption (2017-2022)
-
7.2 United States Hematologic Malignancies Consumption (2017-2022)
-
7.3 Europe Hematologic Malignancies Consumption (2017-2022)
-
7.4 China Hematologic Malignancies Consumption (2017-2022)
-
7.5 Japan Hematologic Malignancies Consumption (2017-2022)
-
7.6 India Hematologic Malignancies Consumption (2017-2022)
-
7.7 South Korea Hematologic Malignancies Consumption (2017-2022)
8 Region and Country-wise Hematologic Malignancies Market Analysis and Outlook to 2028
-
8.1 Global Hematologic Malignancies Consumption Forecast (2022-2028)
-
8.2 United States Hematologic Malignancies Consumption Forecast (2022-2028)
-
8.3 Europe Hematologic Malignancies Consumption Forecast (2022-2028)
-
8.4 China Hematologic Malignancies Consumption Forecast (2022-2028)
-
8.5 Japan Hematologic Malignancies Consumption Forecast (2022-2028)
-
8.6 India Hematologic Malignancies Consumption Forecast (2022-2028)
-
8.7 South Korea Hematologic Malignancies Consumption Forecast (2022-2028)
9 Global Hematologic Malignancies Market Outlook by Types and Applications to 2022
-
9.1 Global Hematologic Malignancies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Leukemia Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lymphoma Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hematologic Malignancies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Stem Cell Transplantation Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hematologic Malignancies Market Outlook by Types and Applications to 2028
-
10.1 Global Hematologic Malignancies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hematologic Malignancies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Stem Cell Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hematologic Malignancies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hematologic Malignancies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hematologic Malignancies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hematologic Malignancies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hematologic Malignancies Market Competitive Analysis
-
14.1 Nоvаrtіѕ АG
-
14.1.1 Nоvаrtіѕ АG Company Details
-
14.1.2 Nоvаrtіѕ АG Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Nоvаrtіѕ АG Hematologic Malignancies Product and Service
-
14.2 Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd
-
14.2.1 Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd Company Details
-
14.2.2 Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd Hematologic Malignancies Product and Service
-
14.3 Ѕаnоfі-Аvеntіѕ
-
14.3.1 Ѕаnоfі-Аvеntіѕ Company Details
-
14.3.2 Ѕаnоfі-Аvеntіѕ Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Ѕаnоfі-Аvеntіѕ Hematologic Malignancies Product and Service
-
14.4 Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ
-
14.4.1 Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ Company Details
-
14.4.2 Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ Hematologic Malignancies Product and Service
-
14.5 Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу
-
14.5.1 Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу Company Details
-
14.5.2 Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу Hematologic Malignancies Product and Service
-
14.6 F Ноffmаnn-LА Rосhе ltd
-
14.6.1 F Ноffmаnn-LА Rосhе ltd Company Details
-
14.6.2 F Ноffmаnn-LА Rосhе ltd Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 F Ноffmаnn-LА Rосhе ltd Hematologic Malignancies Product and Service
-
14.7 Сеlgеnе Соrроrаtіоn
-
14.7.1 Сеlgеnе Соrроrаtіоn Company Details
-
14.7.2 Сеlgеnе Соrроrаtіоn Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Сеlgеnе Соrроrаtіоn Hematologic Malignancies Product and Service
-
14.8 Іnс
-
14.8.1 Іnс Company Details
-
14.8.2 Іnс Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Іnс Hematologic Malignancies Product and Service
-
14.9 Рfіzеr Іnс
-
14.9.1 Рfіzеr Іnс Company Details
-
14.9.2 Рfіzеr Іnс Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Рfіzеr Іnс Hematologic Malignancies Product and Service
-
14.10 АbbVіе Іnс
-
14.10.1 АbbVіе Іnс Company Details
-
14.10.2 АbbVіе Іnс Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 АbbVіе Іnс Hematologic Malignancies Product and Service
-
14.11 GlахоЅmіthКlіnе РLС
-
14.11.1 GlахоЅmіthКlіnе РLС Company Details
-
14.11.2 GlахоЅmіthКlіnе РLС Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GlахоЅmіthКlіnе РLС Hematologic Malignancies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hematologic Malignancies
-
Figure Hematologic Malignancies Picture
-
Table Global Hematologic Malignancies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hematologic Malignancies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hematologic Malignancies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hematologic Malignancies Consumption by Country (2017-2022)
-
Figure United States Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
Table Europe Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
Figure China Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
Figure Japan Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
Figure India Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
Figure Global Hematologic Malignancies Consumption Forecast by Country (2022-2028)
-
Figure United States Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Transplantation Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stem Cell Transplantation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hematologic Malignancies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hematologic Malignancies Export by Region (Top 5 Countries) (2017-2028)
-
Table Nоvаrtіѕ АG (Foundation Year, Company Profile and etc.)
-
Table Nоvаrtіѕ АG Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nоvаrtіѕ АG Hematologic Malignancies Product and Service
-
Table Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd (Foundation Year, Company Profile and etc.)
-
Table Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Таkеdа Рhаrmасеutісаl Соmраnу lіmіtеd Hematologic Malignancies Product and Service
-
Table Ѕаnоfі-Аvеntіѕ (Foundation Year, Company Profile and etc.)
-
Table Ѕаnоfі-Аvеntіѕ Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ѕаnоfі-Аvеntіѕ Hematologic Malignancies Product and Service
-
Table Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ (Foundation Year, Company Profile and etc.)
-
Table Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Јоhnѕоn & Јоhnѕоn Ѕеrvісеѕ Hematologic Malignancies Product and Service
-
Table Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу (Foundation Year, Company Profile and etc.)
-
Table Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Вrіѕtоl-Муеrѕ Ѕquіbb Соmраnу Hematologic Malignancies Product and Service
-
Table F Ноffmаnn-LА Rосhе ltd (Foundation Year, Company Profile and etc.)
-
Table F Ноffmаnn-LА Rосhе ltd Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Ноffmаnn-LА Rосhе ltd Hematologic Malignancies Product and Service
-
Table Сеlgеnе Соrроrаtіоn (Foundation Year, Company Profile and etc.)
-
Table Сеlgеnе Соrроrаtіоn Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Сеlgеnе Соrроrаtіоn Hematologic Malignancies Product and Service
-
Table Іnс (Foundation Year, Company Profile and etc.)
-
Table Іnс Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Іnс Hematologic Malignancies Product and Service
-
Table Рfіzеr Іnс (Foundation Year, Company Profile and etc.)
-
Table Рfіzеr Іnс Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Рfіzеr Іnс Hematologic Malignancies Product and Service
-
Table АbbVіе Іnс (Foundation Year, Company Profile and etc.)
-
Table АbbVіе Іnс Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table АbbVіе Іnс Hematologic Malignancies Product and Service
-
Table GlахоЅmіthКlіnе РLС (Foundation Year, Company Profile and etc.)
-
Table GlахоЅmіthКlіnе РLС Hematologic Malignancies Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlахоЅmіthКlіnе РLС Hematologic Malignancies Product and Service
-
